Search
for

    Sort by

    Research

    150-180 / 1000+ results
      ULBP3: A Marker for Alopecia Areata Incognita

      research ULBP3: a marker for alopecia areata incognita

      15 citations , May 2016 in “Archives of Dermatological Research”
      This study found significantly higher levels of the protein ULBP3 in patients with alopecia areata incognita compared to other hair loss conditions and healthy controls, suggesting ULBP3's potential as a diagnostic marker for AAI.
      Mechanism of PPARα Agonist in Alopecia Areata

      research Mechanism of PPARα agonist in alopecia areata

      1 citations , January 2025 in “American Journal of Translational Research”
      This study found that PPARα agonists provided protective effects in mouse models of alopecia areata by promoting early reversal of the condition and inhibiting T effector cell function, indicating potential therapeutic value for this inflammatory condition.

      research Vitiligo and alopecia areata: apples and oranges?

      71 citations , October 2013 in “Experimental Dermatology”
      This review discusses the similar immune pathways and genetic risk factors of vitiligo and alopecia areata but reports no new clinical findings, emphasizing the potential for shared treatment research.

      research 66-Year-Old Female with Itchy Scalp and Hair Loss

      January 2022 in “Clinical Cases in Dermatology”
      This article discusses the causes and treatment options for lichen planopilaris, a scarring hair loss condition, but reports no new clinical findings.

      research Engineering a New Mouse Model for Vitiligo

      5 citations , June 2012 in “Journal of Investigative Dermatology”
      Harris et al. describe a new mouse model for vitiligo, where interfollicular melanocytes are retained and melanocyte-targeting immune responses are simulated, aiding the development of immunomodulatory therapies.

      research Postmenopausal hyperandrogenism of ovarian origin

      October 2025 in “F1000Research”
      In this case series, the authors reported that postmenopausal hyperandrogenism should be carefully evaluated to diagnose potential androgen-secreting tumors, with Sertoli-Leydig cell tumors identified as a common cause.
      Epidermolysis Bullosa

      research Epidermolysis Bullosa

      January 2023 in “Springer eBooks”
      This review discusses the causes, characteristics, and current management strategies for epidermolysis bullosa, emphasizing that while experimental therapies show promise, there are no definitive cures.

      research Frontiers in alopecia areata pathobiology research

      55 citations , October 2019 in “ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology”
      This review discusses emerging research areas in alopecia areata pathobiology, highlighting the potential roles of unconventional immune cells and the need for more targeted therapeutic strategies, but reports no new experimental results.
      Skin Fibroblast Functional Heterogeneity in Health and Disease

      research Skin fibroblast functional heterogeneity in health and disease

      1 citations , August 2023 in “The Journal of Pathology”
      In this source, recent single-cell RNA-sequencing advances reveal significant transcriptional heterogeneity among skin fibroblasts, and the discussion focuses on the distinct subtypes' roles in skin homeostasis, repair, and their evolution in fibrotic diseases like keloid scars and cancer.
      Fibroblast Heterogeneity: Implications for Human Disease

      research Fibroblast heterogeneity: implications for human disease

      299 citations , January 2018 in “Journal of Clinical Investigation”
      This review explores fibroblast heterogeneity in the mammalian dermis and suggests potential therapeutic applications by targeting fibroblast subtypes, but reports no new experimental results.
      Immunology

      research 9. Immunology

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.
      Phototherapy, Photomedicine, and Pigmentary Disorders

      research 6. Phototherapy, Photomedicine, and Pigmentary Disorders

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.
      Medical Practice: Therapy and Adverse Reactions

      research 1. Medical Practice; Therapy; Adverse Reactions

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.
      MicroRNA in Skin Diseases

      research MicroRNA in skin diseases

      27 citations , July 2017 in “European Journal of Dermatology”
      This article reviews the role of microRNAs as epigenetic modulators in dermatology but reports no new clinical findings.
      Contents

      research Contents

      May 2010 in “Dermatologic Clinics”
      The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.